Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.

[1]  Jim Euchner.  Design , 2014, Catalysis from A to Z.

[2]  Fanbo Jing,et al.  Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. , 2011, Bioorganic & Medicinal Chemistry.

[3]  P. Kerry,et al.  Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase , 2010, Nature communications.

[4]  Thomas S. Peat,et al.  Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses† , 2010, Journal of medicinal chemistry.

[5]  Jianzhu Chen,et al.  Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus. , 2010, Journal of pharmaceutical sciences.

[6]  A. Yang,et al.  Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. , 2010, Bioorganic & medicinal chemistry.

[7]  B. Seong,et al.  Reverse genetic platform for inactivated and live-attenuated influenza vaccine , 2010, Experimental & Molecular Medicine.

[8]  B. Seong,et al.  Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses , 2010, Microbiology and immunology.

[9]  J. Magano.  Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza. , 2009, Chemical reviews.

[10]  Chi‐Huey Wong,et al.  Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus. , 2009, Journal of medicinal chemistry.

[11]  M. Yamashita,et al.  Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en. , 2009, Bioorganic & medicinal chemistry letters.

[12]  Steven J. M. Jones,et al.  A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. , 2009, Journal of medicinal chemistry.

[13]  F. Totzke,et al.  N-substituted 2'-(aminoaryl)benzothiazoles as kinase inhibitors: hit identification and scaffold hopping. , 2009, Bioorganic & medicinal chemistry letters.

[14]  Hualiang Jiang,et al.  Efficient dehydrative sialylation of C-4-aminated sialyl-hemiketal donors with Ph2SO/Tf2O. , 2009, The Journal of organic chemistry.

[15]  Hualiang Jiang,et al.  Simultaneous 2-O-deacetylation and 4-amination of peracetylated Neu5Ac: application to the synthesis of (4 -> 4)-piperazine derivatives linked sialic acid dimers , 2008 .

[16]  Alan J. Hay,et al.  Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants , 2008, Nature.

[17]  Hualiang Jiang,et al.  Simultaneous Stereoselective 4-Amination with Cyclic Secondary Amines and 2-O-Deacetylation of Peracetylated Sialic Acid Derivatives. , 2007 .

[18]  Zhuo-rong Li,et al.  Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir). , 2007, Bioorganic & medicinal chemistry letters.

[19]  Hualiang Jiang,et al.  Simultaneous stereoselective 4-amination with cyclic secondary amines and 2-O-deacetylation of peracetylated sialic acid derivatives , 2007 .

[20]  E. De Clercq,et al.  Anti‐influenza virus agents: Synthesis and mode of action , 2006, Medicinal research reviews.

[21]  Weiliang Zhu,et al.  Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities. , 2006, Bioorganic & medicinal chemistry letters.

[22]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[23]  Jie Zhang,et al.  Recent advances in anti-influenza agents with neuraminidase as target. , 2006, Mini reviews in medicinal chemistry.

[24]  Alexey Bochkarev,et al.  An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. , 2005, Journal of molecular biology.

[25]  Stephanie Hamilton,et al.  Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. , 2005, Journal of medicinal chemistry.

[26]  Tianbao Lu.  Oxyguanidines. Part 2. Discovery of a Novel Orally Active Thrombin Inhibitor Through Structure-Based Drug Design and Parallel Synthesis. , 2004 .

[27]  R. Webster,et al.  Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses , 2001, Antimicrobial Agents and Chemotherapy.

[28]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors. , 2007, Nature reviews. Drug discovery.

[29]  Jonathan Greer,et al.  Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series. , 2003, Biochemistry.

[30]  P. Wyatt,et al.  Approaches to carbocyclic analogues of the potent neuraminidase inhibitor 4-guanidino-Neu5Ac2en. X-Ray molecular structure of N-[(1S,2S,6R)-2-azido-6-benzyloxymethyl-4-formylcyclohex-3-enyl]acetamide , 1995 .